SEC Form 3 · accession 0001741253-18-000001
InventaBioTech Inc. · INVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Knott
Officer — Chief Science Officer · Director
Period of report
Apr 3, 2018
Accepted (ET)
May 21, 2018 · 11:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421603
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 183,674 | D |
Table II — derivative securities
No Table II lines on this filing.